Location History:
- Elnhausen, DE (2001 - 2006)
- Marburg, DE (1998 - 2016)
Company Filing History:
16 out of 149 
4 out of 74 
3 out of 39 Years Active: 1998-2016
Title: Innovations of Hans-Peter Hauser in Coagulation Factor X Research
Introduction
Hans-Peter Hauser is a prominent inventor located in Marburg, Germany, known for his significant contributions to the field of biotechnology and the development of coagulation factor X polypeptides. With an impressive portfolio of 25 patents, Hauser has been instrumental in advancing our understanding and manipulation of blood coagulation processes, which are critical in medical applications such as gene therapy and treatment of bleeding disorders.
Latest Patents
Among his latest innovations, Hauser has developed modified cDNA sequences coding for factor X polypeptides, specifically focusing on human factor X and its derivatives. These inventions offer a groundbreaking approach to bypassing the need for either factor VIIIa/factor IXa or factor VIIa/tissue factor for activation. His patents also include recombinant expression vectors containing these modified cDNA sequences, along with host cells transformed with such vectors.
Furthermore, Hauser’s research has led to the creation of recombinant factor X polypeptides and derivatives that maintain the biological activities of the unmodified wild-type protein but feature improved stability and modified activation properties. These advancements are crucial for processes aimed at producing such recombinant proteins and their derivatives. Notably, his inventions contribute to developing transfer vectors for use in human gene therapy, which incorporate these modified DNA sequences.
Career Highlights
Throughout his career, Hauser has worked with leading companies in the biotechnology sector, including Dade Behring Marburg GmbH and CSL Behring GmbH. His work in these organizations has allowed him to bring his innovative ideas from concept to practical application, further solidifying his reputation as a leading inventor in his field.
Collaborations
Notable collaborations have been key to Hauser's success, including partnerships with distinguished colleagues such as Stefan Knapp and Josef Eberle. Together, they have contributed to the development and enhancement of various inventions related to coagulation factor X, showcasing the importance of teamwork in scientific innovation.
Conclusion
In summary, Hans-Peter Hauser has made substantial contributions to the field of biotechnology, particularly in the development of modified coagulation factor X polypeptides. His extensive patent portfolio and collaborations with leading companies and researchers highlight his innovative spirit and dedication to advancing medical science. As research continues to evolve, Hauser's work remains critical in improving therapeutic strategies for managing clotting disorders and advancing gene therapy techniques.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.